Venus Concept Announces 1-for-11 Reverse Stock Split
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it will effect a 1-for-11 reverse stock split of the Company’s ...
Insider3h
PE-backed medical technology company secures $142m to accelerate growth opportunities in organ technology market
A PE-backed medical technology company in Oxford specialising in organ preservation has completed a $142m primary and secondary equity financing.
Axios on MSN22h
OrganOx raises $142 million to help liver transplants
OrganOx, a British developer of technologies to maintain organs for transplant, raised $142m in primary and secondary funding ...